# The Performance of Multi-tracer Multimodality PET in Lymphoma

> **NCT05004961** · — · UNKNOWN · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 200 (estimated)

## Conditions studied

- Positron-Emission Tomography

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05004961
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-15
- **Primary completion:** 2023-08-15
- **Final completion:** 2023-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05004961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05004961, "The Performance of Multi-tracer Multimodality PET in Lymphoma". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05004961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*